C032 Is allogeneic hematopoietic cell transplantation a reasonable therapeutic option for elderly (>60 years) patients with de novo myelodysplastic syndromes?

Autor: Platzbecker, U., Trenschel, R., Schaefer-Eckart, K., Theuser, C., Bornhaeuser, M., Ehninger, G., Beelen, D.
Zdroj: In Leukemia Research 2009 33 Supplement 1:S50-S51
Databáze: ScienceDirect